Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,472.03
(
-0.26%
)
News Focus
News Focus
Post# of 517743
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

XenaLives

Send PM Follow Ignore
Followers 480
Posts 61846
Boards Moderated 15
Alias Born 09/20/2001

XenaLives

Member Level

Re: Investor2014 post# 257641

Sunday, 07/05/2020 10:05:06 AM

Sunday, July 05, 2020 10:05:06 AM

Post# of 517743
If (4) proves true the TGA could also decide that benefit was better than SOC and give provisional approval.

4. The precision medicine approach is now being tested in the current controlled trials to see if the data driven biomarker hypothesis can be confirmed
5. If (4) proves true, then the next trials will be precision medicine trials selecting patient enrollment on confirmed biomarkers


Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News